DYNAVAX TECHNOLOGIES CORP (DVAX) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-02-11

DYNAVAX TECHNOLOGIES CORP (DVAX) — no SEC Form 4 insider filings recorded in the last 90 days. InsiderAlpha tracks every DVAX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About DYNAVAX TECHNOLOGIES CORP (DVAX)

SIC classification	Pharmaceutical Preparations (SIC 2834)
SEC CIK	0001029142

Recent DVAX Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-02-10	Slebir John L	SVP General Counsel	D — Derivative transaction	42.4K	—	—	SEC
2026-02-10	MacDonald Kelly	SVP and CFO	D — Derivative transaction	46.4K	—	—	SEC
2026-02-10	Slebir John L	SVP General Counsel	A — Grant or award	42.4K	—	—	SEC
2026-02-10	Slebir John L	SVP General Counsel	J — Other acquisition / disposition	69.6K	—	—	SEC
2026-02-10	MacDonald Kelly	SVP and CFO	J — Other acquisition / disposition	60.2K	—	—	SEC
2026-02-10	MacDonald Kelly	SVP and CFO	A — Grant or award	46.4K	—	—	SEC
2026-02-10	Spencer Ryan	CEO and Director	D — Derivative transaction	165.0K	—	—	SEC
2026-02-10	Spencer Ryan	CEO and Director	A — Grant or award	165.0K	—	—	SEC
2026-02-10	Spencer Ryan	CEO and Director	D — Derivative transaction	136.0K	—	—	SEC
2026-02-10	Spencer Ryan	CEO and Director	A — Grant or award	136.0K	—	—	SEC
2026-02-10	Slebir John L	SVP General Counsel	D — Derivative transaction	50.0K	—	—	SEC
2026-02-10	Metzinger Joseph Anthony	VP, Chief Accounting Officer	J — Other acquisition / disposition	7.1K	—	—	SEC
2026-02-10	Slebir John L	SVP General Counsel	A — Grant or award	50.0K	—	—	SEC
2026-02-10	Spencer Ryan	CEO and Director	J — Other acquisition / disposition	379.6K	—	—	SEC
2026-02-10	MacDonald Kelly	SVP and CFO	A — Grant or award	42.4K	—	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for DYNAVAX TECHNOLOGIES CORP (DVAX). Updated in real time as new filings are submitted to the SEC.

Recent Insider Filings

2026-02-11 — Deep Track Biotechnology Master Fund, Ltd. (Insider)
2026-02-10 — Spencer Ryan (CEO and Director)
2026-02-10 — Slebir John L (SVP General Counsel)
2026-02-10 — Metzinger Joseph Anthony (VP, Chief Accounting Officer)
2026-02-10 — MacDonald Kelly (SVP and CFO)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in DVAX insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

DVAX Insider Trading — FAQ

What is the latest insider trade for DVAX?: DYNAVAX TECHNOLOGIES CORP (DVAX) had 0 insider filings in the last 90 days, with the most recent on 2026-02-11. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying DVAX stock?: 0 insider purchases of DVAX were filed in the last 90 days.
How many insiders are selling DVAX stock?: 0 insider sales of DVAX were filed in the last 90 days.
Where can I see DVAX SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every DVAX SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Related Companies — Recent Insider Activity

Learn More

Open the live DVAX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.